Skip to main content Accessibility help
×
Home

Multidrug Resistance among Gram-Negative Pathogens That Caused Healthcare-Associated Infections Reported to the National Healthcare Safety Network, 2006–2008

  • Alexander J. Kallen (a1), Alicia I. Hidron (a1) (a2), Jean Patel (a1) and Arjun Srinivasan (a1)

Abstract

We evaluated isolates of Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii that were reported to the National Healthcare Safety Network from January 2006 through December 2008 to determine the proportion that represented multidrug-resistant phenotypes. The pooled mean percentage of resistance varied by the definition used; however, multidrug resistance was relatively common and widespread.

Copyright

Corresponding author

1600 Clifton Rd NE, MS A-35, Atlanta, Georgia30333, (AKallen@cdc.gov)

References

Hide All
1.Maragakis, LL, Cosgrove, SE, Song, X, et al.An outbreak of multidrug-resistant Acinetobacter baumannii associated with pulsatile lavage wound treatment. JAMA 2004;292:30063011.
2.Lolans, K, Rice, TW, Munoz-Price, LS, Quinn, JRMulti-city outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40. Antimicrob Agents Chemother 2006;50:29412945.
3.Woodford, N, Tierno, PM Jr, Young, K, et al.Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A β-lacta-mase, KPC-3, in a New York medical center. Antimicrob Agents Chemother 2004;48:47934799.
4.Bratu, S, Landman, D, Haag, R, et al.Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium. Arch Intern Med 2005;165:14301435.
5.Karlowsky, JA, Draghi, DC, Jones, ME, Thornsberry, C, Friedland, IR, Sahm, DF. Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998-2001. Antimicrob Agents Chemother 2003;47:16811688.
6.Obritsch, MD, Fish, DN, McLaren, R, Jung, R. National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993 to 2002. Antimicrob Agents Chemother 2004;48:46064610.
7. US Census Bureau. Census Regions and Divisions of the United States. http://www.census.gov/geo/www/us_regdiv.pdf. Accessed September 28, 2009.
8.Hidron, AI, Edwards, JE, Patel, J, et al.Antimicrobial-resistant pathogens associated with healthcare-associated infections: annual survey of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008;29:9961011.
9.Falagas, ME, Karageorgopoulos, DE. Pandrug resistance, extensive drug resistance, and multidrug resistance among gram-negative bacilli: need for international harmonization in terminology. Clin Infect Dis 2008;46:11211122.
10. Management of multidrug-resistant organisms in healthcare settings, 2006. Healthcare Infection Control Practices Advisory Committee, http://www.cdc.gov/ncidod/dhqp/pdf/ar/mdroGuideline2006.pdf. Accessed August 4, 2009.
11.Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. MMWR 2009;58:256260.

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed